Panelists discuss how policy makers can increase biosimilar adoption through financial incentives, streamlined interchangeability rules, and addressing patent litigation delays, emphasizing that biosimilar savings will ultimately help fund the next wave of health care innovation such as cell and gene therapies.
Policy Considerations and Future Directions
Key Themes:
Key Points for Physicians:
Notable Insights:
Implementing biosimilars represents an opportunity for health care organizations to demonstrate good stewardship of limited health care resources while maintaining quality care.
Clinical Significance: Policy interventions that streamline interchangeability, align stakeholder incentives, and address patent litigation delays can accelerate biosimilar adoption, ultimately enabling investment in next-generation therapies while maintaining sustainable health care costs.
Physician Peer Influence Drives Uptake of Opportunistic Salpingectomy for Ovarian Cancer Prevention
October 9th 2025Surgeons are more likely to perform opportunistic salpingectomy when their peers have done so, underscoring the impact of physician networks in ovarian cancer prevention.
Read More